The Cytokinesis-Blocked Micronucleus Assay as a Strong Predictor of Lung Cancer: Extension of a Lung Cancer Risk Prediction Model

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2014-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-14-0462PMID 25172871PMCID PMC4487661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The contribution of risk prediction models to early detection of lung cancer

  2013cited by this paper
• A risk model for lung cancer incidence.

  2012cited by this paper
• Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements

  2012cited by this paper
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

  2012cited by this paper
• Use of the Cytokinesis-Blocked Micronucleus Assay to Detect Gender Differences and Genetic Instability in a Lung Cancer Case–Control Study

  2012cited by this paper
• DNA breaks and chromosome pulverization from errors in mitosis

  2012cited by this paper
• Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

  2011cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project

  2010cited by this paper
• Cancer facts and figures

  2010cited by this paper
• Human population studies with the exfoliated buccal micronucleus assay: statistical and epidemiological issues.

  2010cited by this paper
• Comparison of discriminatory power and accuracy of three lung cancer risk models

  2010cited by this paper
• Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.

  2009cited by this paper
• Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• An Expanded Risk Prediction Model for Lung Cancer

  2008cited by this paper
• Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers

  2008cited by this paper
• Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

  2008cited by this paper
• A risk model for prediction of lung cancer.

  2007cited by this paper
• Cytokinesis-block micronucleus cytome assay

  2007cited by this paper
• The LLP risk model: an individual risk prediction model for lung cancer

  2007cited by this paper
• Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk.

  2006cited by this paper
• Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity.

  2005cited by this paper
• Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective

  2004cited by this paper
• Variations in lung cancer risk among smokers.

  2003cited by this paper
• HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures.

  2003cited by this paper
• Biomarkers of genetic damage for cancer epidemiology.

  2002cited by this paper
• Chromosomal biomarkers of genomic instability relevant to cancer.

  2002cited by this paper
• The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder.

  2001cited by this paper
• Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations.

  2000influential reference
• The in vitro micronucleus technique.

  2000cited by this paper
• Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.

  2000cited by this paper
• Cytokinesis-block micronucleus assay in WIL2-NS cells: a sensitive system to detect chromosomal damage induced by reactive oxygen species and activated human neutrophils.

  2000cited by this paper
• Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.

  1999cited by this paper
• Cancer predictive value of cytogenetic markers used in occupational health surveillance programs.

  1998cited by this paper
• Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment.

  1996cited by this paper
• Preneoplastic lesions, DNA adduct formation and mutagenicity of 5-, 7- and 9-hydroxy-2-nitrofluorene, metabolites of the air pollutant 2-nitrofluorene.

  1996cited by this paper
• Lung cancer detection and prevention: evidence for an interaction between smoking and genetic predisposition.

  1992cited by this paper
• Chromosome aberrations and cancer.

  1991cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• Measurement of micronuclei in lymphocytes.

  1985cited by this paper
• Three consistent patterns of response to substituted acridines in a variety of bacterial tester strains used for mutagenicity testing.

  1985cited by this paper
• Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.

  1978cited by this paper
• Cancer,Facts and Figures about.

  year unknowncited by this paper

• Construction of a Lung Cancer Screening Risk Prediction Model Based on Machine Learning Algorithms.

  2026cites this paper
• Predictive performance of risk prediction models for lung cancer incidence in Western and Asian countries: a systematic review and meta-analysis

  2025cites this paper
• In Vitro Toxicological Evaluation of nicotine concentration and flavor variants of Vuse Alto ENDS.

  2025cites this paper
• High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)

  2025cites this paper
• Toxic effect of polycyclic aromatic hydrocarbons (PAHs) on co-culture model of human alveolar epithelial cells (A549) and macrophages (THP-1)

  2024cites this paper
• Objectives and Achievements of the HUMN project on its 26th Anniversary.

  2024cites this paper
• Development and validation of a tumor marker-based model for the prediction of lung cancer: an analysis of a multicenter retrospective study in Shanghai, China

  2024cites this paper
• 大规模人群队列生活行为方式相关的肺癌风险预测模型的构建

  2023cites this paper
• Development of lung cancer risk prediction models based on F-18 FDG PET images

  2023cites this paper
• Lung Cancer Risk Prediction Nomogram in Nonsmoking Chinese Women: Retrospective Cross-sectional Cohort Study

  2023cites this paper
• Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China

  2022cites this paper
• Increased oxidative and chromosomal DNA damage in patients with ankylosing spondylitis: its role in pathogenesis

  2022cites this paper
• Induction of DNA damage as a consequence of occupational exposure to crystalline silica: A review and meta-analysis.

  2021cites this paper
• A risk prediction model for selecting high-risk population for computed tomography lung cancer screening in China.

  2021cites this paper
• Roadmap for translating results from the micronucleus assay into clinical practice: From observational studies to randomized controlled trials.

  2021cites this paper
• Genomic instability in chronic obstructive pulmonary disease and lung cancer: A systematic review and meta-analysis of studies using the micronucleus assay.

  2021cites this paper
• Lung cancer screening: who pays? Who receives? The European perspectives

  2021cites this paper
• Mitotic Spindle Apparatus Abnormalities in Chronic Obstructive Pulmonary Disease Cells: A Potential Pathway to Lung Cancer

  2020cites this paper
• Micronuclei and disease - Report of HUMN project workshop at Rennes 2019 EEMGS conference.

  2020cites this paper
• Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population

  2020cites this paper
• Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.

  2020cites this paper
• Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

  2020cites this paper
• Risk-Based lung cancer screening: A systematic review.

  2020cites this paper
• Retinol palmitate against toxicogenic damages of antineoplastic drugs on normal and tumor cells.

  2020cites this paper
• Highlight article: Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients

  2019cites this paper
• Multiple metals exposure and chromosome damage: Exploring the mediation effects of microRNAs and their potentials in lung carcinogenesis.

  2019cites this paper
• Characterization of urban aerosol: Seasonal variation of genotoxicity of the water-soluble portion of PM2.5 and PM1.

  2019cites this paper
• Effect of Benzo[a]Pyrene on Spindle Misorientation and Fidelity of Chromosome Segregation in Lung Epithelial BEAS-2B Cells

  2018cites this paper
• Micronuclei and What They Can Tell Us in Cytogenetic Diagnostics

  2018cites this paper
• The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants.

  2018cites this paper
• Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls.

  2018cites this paper
• Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

  2017cites this paper
• Increased Chromosomal and Oxidative DNA Damage in Patients with Multinodular Goiter and Their Association with Cancer

  2017cites this paper
• Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions

  2017cites this paper
• Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays

  2017cites this paper
• Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma

  2016cites this paper
• Ultrastructural changes during lung carcinogenesis-modulation by curcumin and quercetin

  2016cites this paper
• Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

  2015cites this paper
• Application of risk prediction models to lung cancer screening: a review.

  2015cites this paper